Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children.
Fractional exhaled nitric oxide measurements are most closely associated with allergic sensitization in school-age children.
复制标题
DOI:
10.1016/j.jaci.2009.07.024
复制
发表时间:
2009-11
影响因子:
14.2
通讯作者:
Lemanske, Robert F., Jr.
中科院分区:
文献类型:
--
作者:
Jackson, Daniel J.;Virnig, Christine M.;Gangnon, Ronald E.;Evans, Michael D.;Roberg, Kathy A.;Anderson, Elizabeth L.;Burton, Ryan M.;Salazar, Lisa P.;DaSilva, Douglas F.;Shanovich, Kathleen M.;Tisler, Christopher J.;Gern, James E.;Lemanske, Robert F., Jr.
关键词:
Factors affecting fractional exhaled nitric oxide (FeNO) in early childhood are incompletely understood. To examine the relationships between FeNO and allergic sensitization, total IgE, atopic dermatitis, rhinitis, asthma, and lung function (spirometry) in children. Children at high-risk of asthma and other allergic diseases due to parental history were enrolled at birth and followed prospectively. FeNO was measured by online technique at ages 6 and 8 years. Relationships among FeNO, various atopic characteristics, and asthma were evaluated. Reproducible FeNO measurements were obtained in 64% (135 of 210) of 6 year old and 93% (180 of 194) of 8 year old children. There was seasonal variability in FeNO. Children with aeroallergen sensitization at age 6 and 8 years had increased levels of FeNO compared to those not sensitized [geometric mean (6 years, 10.9 vs. 6.7 ppb, p<0.0001; 8 years, 14.6 vs. 7.1 ppb, p<0.0001)]. FeNO was higher in children with asthma than in those without asthma at 8 years, but not 6 years of age (6 years, 9.2 vs. 8.3 ppb, p = 0.48; 8 years, 11.5 vs. 9.2 ppb, p = 0.03). At 8 years of age, this difference was no longer significant in a multivariate model that included aeroallergen sensitization (p=0.33). There were no correlations between FeNO and spirometric indices at 6 or 8 years of age. These findings underscore the importance of evaluating allergen sensitization status when FeNO is used as a potential biomarker in the diagnosis and/or monitoring of atopic diseases, particularly asthma. When FeNO is utilized as a biomarker for the diagnosis and/or monitoring of atopic diseases such as asthma, the presence or absence of allergic sensitization should be carefully considered. This pediatric cohort study evaluates the relationships between FeNO and various atopic characteristics. The results suggest that allergic sensitization should be evaluated when FeNO is used as a biomarker in clinical or research settings.
登录
查看更多内容
影响因子:
12.4
作者:
Nordvall, SL;Janson, C;Alving, K
通讯作者:
Alving, K
影响因子:
5.9
作者:
van Asch, Charlotte J. J.;Balemans, Walter A. F.;van der Ent, Cornelis K.
通讯作者:
van der Ent, Cornelis K.
影响因子:
4.4
作者:
Barreto, M;Villa, MP;Ronchetti, R
通讯作者:
Ronchetti, R
影响因子:
0.9
作者:
Paul, EF
通讯作者:
Paul, EF
影响因子:
10
作者:
Steerenberg, PA;Janssen, NAH;van Amsterdam, JGC
通讯作者:
van Amsterdam, JGC